As the newest member of the Applied Machine Learning team based in Boston Sara is excited to meet with you and brainstorm to define projects and form collaborations. She is a Bioinformatics and Computational Medicine researcher, expert in integration, analysis, visualization, and interpretation of (pre)clinical and high-throughput data. Her work involves developing algorithms to apply machine learning, heterogeneous data integration, and, 'omic' data and sizeable networks analysis to study complex genetic diseases (e.g., cancer and autoimmune disease), therapeutics response prediction, and computational functional genomics. Sara has over fifteen years of experience working and presenting in highly multidisciplinary teams of MDs, computational scientists, and biologists., and, writing articles and grant applications.

I am a "Senior Insight Solutions Lead" which means that I work in DAIS team and try to generate novel insights for our R&D (and beyond) organization

Thank you for the chat!

I am a pharmacist from Rio de Janeiro-Brazil and I work as a computational chemist at Bayer since 2021 in the Computational Molecular Design department in Wuppertal. I work side by side with chemists on different projects using our digital tools to design small molecules that maybe one day will help patients! I am passionate about my work and I have the opportunity to also be part of the Steering Group for Transformation and Leadership in the Drug Discovery Science to help transforming the way we work and communicate.

I studied piano performance and toxicology, and am now Master Data Manager at Bayer Pharma in the R&D Master Data Management team of Data Science & AI. I am passionate about team collaboration and rowing. Currently, I'm co-leading the IDMP Ontology, an international cross-industry project with 12 pharma companies for the unique identification of medicinal products to ensure patient safety. Talk to me about common standards and high quality data for better ML and AI outcomes, our next collaboration project, and/or our next jam session at the Bayer Berlin campus.

ChemogenomicsDB (CGDB) and Älixir are prime examples of creating data assets and insight solutions to help improve digital and data capabilities, enhance scientific productivity, and invigorate early pipeline. Using our products, Bayer R&D colleagues can - access to a broad range of data assets essential for solving key drug discovery questions - explore integrated biomedical and chemical data for scientific curiosity, inspiration, and knowledge discovery - generate insights with the assistance of interactive visualizations for evidence-informed decision making